Searchable abstracts of presentations at key conferences in endocrinology

ea0012p43 | Diabetes, metabolism and cardiovascular | SFE2006

What is the relationship between testosterone and fat mass in young male cancer survivors and healthy controls?

Greenfield DM , Walters SJ , Eastell R , Coleman RE , Hancock BW , Snowden J , Ross RJ

Background and AimIt is known that the variability of testosterone concentrations is predictive of both truncal and peripheral obesity in healthy men. The aim of this study was to establish the nature of the relationship between testosterone and fat mass in young male cancer survivors compared with healthy controls.Subjects176 male cancer survivors (mean age 37.3 years SD 5.8) who previously received gonadoto...

ea0005p185 | Neuroendocrinology and Behaviour | BES2003

Abnormal endocrine tests in chronic pain require investigation and are not the result of opioid analgesia

Merza Z , Edwards N , Walters S , Newell-Price J , Ross R

Background: Anecdotally patients with chronic pain on opioid analgesia have functional hypopituitarism, and studies in opioid addicts show suppressed pituitary function. We conducted a prospective observational study to determine the endocrine status of patients with chronic pain on opioid analgesia. Methods: 37 consecutive patients with chronic back pain attending the pain clinic were enrolled. 22 patients (age 45+/-9 years) were on long-term opioid analgesia and 15 (age 53 +...

ea0002p95 | Steroids | SFE2001

THE UTILITY OF BASAL ACTH MEASUREMENT DURING MORNING SYNACTHEN TESTING

Chaggar P , Price A , Walters S , Ross R , Weetman A , Newell-Price J

Background: The 250microgram synacthen test may give false negative responses, and will not allow easy discrimination between primary and secondary dysfunction. Furthermore, the use of synacthen is contra-indicated on the data sheet in certain common conditions such as asthma, and may not easily be interpreted in women taking oral oestrogen. Some patients with incipient adrenal failure may have elevated plasma ACTH, whilst passing the synacthen test. We have routinely measured...

ea0042p16 | (1) | Androgens2016

Identification of protein kinases involved in AR transcriptional regulation in prostate cancer

Walker Scott , Banks Peter , Robson Craig , Coffey Kelly

Phosphorylation of the Androgen Receptor (AR), has been shown to play an important role in directly modulating AR activity. However, the full extent of which protein kinases are involved in the regulation of the AR remains unknown. In order to address which kinases are important in the regulation of AR activity in both androgen sensitive and independent prostate cancer (PCa), a comprehensive siRNA kinome screen was performed. AR transcriptional regulation was evaluated using a...

ea0019p374 | Thyroid | SFEBES2009

Clonal relationships between TSH receptor stimulating antibodies illustrate the effect of hypermutation on antibody function

Gilbert J , Padoa C , Larsen S , Hampe C , Dagdan E , Hegedus L , Dunn-Walters D , Banga JP

There is a paucity of information regarding the genetic and somatic mutation events that lead to the production of pathogenic thyroid stimulating antibodies (TSAbs) in Graves’ disease. We have previously isolated two murine monoclonal antibodies (KSAb1 and KSAb2) with potent TSAb activity that demonstrate subtle differences in their interaction with the thyrotropin receptor (TSHR). Analyses of the variable region genes of the heavy and light chains of these TSAbs were per...

ea0005p181 | Neuroendocrinology and Behaviour | BES2003

A randomised double-blind cross-over study of GH treatment in patients over 60 years

Mah P , Walters S , Newell-Price J , Webster J , Doane A , Ibbotson V , Hosker J , Jones T , Ho K , Eastell R , Ross R

AIM: To assess efficacy of GH replacement and safety of stopping treatment in patients aged over 60 years.METHODS: GH-deficient patients were started on GH 0.13 miligram per day and the dose titrated over 4 months to a serum IGF-1 in the upper half of the age-related normal range. After 4 months titration, patients were randomised to either continuing GH or placebo in a double-blind, cross-over study with 2 x 4 month periods of either GH or placebo treatment.RESULTS: 1...

ea0066pens1.1 | (1) | BSPED2019

The evolving role of the children’s endocrine nurse specialist

Walker Jenny

This is a brief reflection on how the role of the children’s endocrine nurse specialist has evolved over the past 24 years and discussion around what the next 24 years may look like. What have we achieved; what is there still to do and what are the major challenges for the future? When days are filled with phone calls, clinics, paper/ computer work, supporting colleagues and caring for patients- we often forget what we have actually achieved and how much our roles have de...

ea0044cmw2.1 | Workshop 2: Adrenal insufficiency and CAH | SFEBES2016

Dynamic control of tissue glucocorticoids and its implications for replacement therapy

Walker Brian

Although Endocrinologists have focused for decades on circulating concentrations of cortisol, arguably the important concentrations are those within tissues which are available at corticosteroid receptors. Tissue concentrations are influenced by plasma proteins binding cortisol, by physicochemical characteristics of the steroid, by active transport across cell membranes, and by steroid metabolism within target tissues. Many of these factors vary between individuals, and within...

ea0039en2 | (1) | BSPED2015

Bones at ground level

Walker Elaine

An overview of current understanding of bone biology. Including new innovations in therapy,bone growth and vitamin D metabolism. An update on bone health for the specialist nurse working in paediatric endocrinology....

ea0013s7 | Society for Endocrinology Medal Lecture | SFEBES2007

Cortisol and cardiovascular disease: from cradle to grave

Walker Brian

Similarities between the metabolic syndrome and Cushing’s syndrome, and reversibility of the features of Cushing’s syndrome, suggest that cortisol may contribute to pathophysiology in both conditions and that reducing cortisol action may provide a novel therapeutic approach in metabolic syndrome.There is substantial evidence that circulating cortisol concentrations are higher in people with hypertension and glucose intolerance. The basis for th...